HHS is standing up two new FDA deputy commissioner posts, with a medtech veteran tipped to oversee AI.
FDA centers lay out a three-stage evidence path for wearable and sensor trial endpoints.
A PLOS Digital Health study finds only three of 1,357 FDA-cleared AI devices were ever tested on patient outcomes.
The FDA cleared Vitestro's Aletta as the first fully autonomous blood draw system in the US.
The FDA's new discussion paper proposes doctor-style competency testing for generative AI medical devices before they reach patients.
FDA marketing authorizations for AI-powered medical tools have passed 1,500, with oncology among the fastest-growing categories.
FDA and CMS hosted 10 AI health companies at a private demo day as they weigh clinical AI policy.
The White House, FDA, and ONC launch a month-long effort to create consensus principles for clinical AI benchmarking.